Coronavirus disease 2019 (COVID-19) can cause variable symptoms ranging from mild common cold-like symptoms to severe life threatening pneumonia. Recent studies show severe outcomes of COVID-19 patients specially in males who suffer from androgenetic alopecia, would be significant and is of particular interest of this study and could help further support the hypothesis that anti-androgen therapy might represents an additional potential intervention against severe COVID-19.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Androgenetic Alopecia Frequency in Participants.
Timeframe: Day 1 of admission
Severity of Androgenetic Alopecia in Patients
Timeframe: Day 1 of admission
300 Participants Mean Age
Timeframe: Day 1 of admission
Disease Outcome as Assessed by Number of Participants Experiencing Better or Worst Outcome With Respect to Age Group.
Timeframe: From date of randomization until the date of clinical improvement (discharge, from ventilator to mask/nasal cannula) or worsening of condtion(from mask/bag to ventilator) or death from any cause, assessed up to 4 months
Disease Outcome as Assessed by Severity of Androgeneic Alopecia in Males
Timeframe: From date of randomization until the date of clinical improvement (discharge, from ventilator to mask/nasal cannula) or worsening of condtion(from mask/bag to ventilator) or death from any cause, assessed up to 4 months
Disease Outcome be Assessed by Severity of Androgenetic Alopecia in Females
Timeframe: From date of randomization until the date of clinical improvement (discharge, from ventilator to mask/nasal cannula) or worsening of condtion(from mask/bag to ventilator) or death from any cause, assessed up to 4 months
Covid-19 Disease Outcomes Correlating With Severity of Androgenetic Alopecia and Age in Females.
Timeframe: From date of randomization until the date of clinical improvement (discharge, from ventilator to mask/nasal cannula) or worsening of condtion(from mask/bag to ventilator) or death from any cause, assessed up to 4 months
Covid-19 Disease Outcomes Correlating With Severity of Androgenetic Alopecia and Age in Males
Timeframe: From date of randomization until the date of clinical improvement (discharge, from ventilator to mask/nasal cannula) or worsening of condtion(from mask/bag to ventilator) or death from any cause, assessed up to 4 months
Hospital Disease Outcome in 300 Subjects. Having 220 Males and 80 Females
Timeframe: Disease outcome during this 4 month duration of study.